Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20266 Citations
5-Amino-1MQ blocks the fat-cell enzyme NNMT, boosting NAD+ and cellular energy burn. Mouse studies show dose-dependent fat loss and metabolic improvement; a 2024 study added grip strength gains in aged animals. No human trials exist. Oral capsules are the community standard, though rodent data questions that route. Research compound only.
50mcg · Daily
Summary: Add 0mL BAC water to your 50mg vial. Draw to < 0.1 units on a U-100 syringe for a 50mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50mg | Daily |
| Moderate | 100mg | Daily |
| Aggressive | 150mg | Daily |
This isn't an injectable. You're taking a capsule. No vials, no bacteriostatic water, no syringes, no reconstitution math. Standard vendor offering is 60 capsules at 50 mg each. Start at 50 mg/day for the first one to two weeks. If you tolerate it, bump to 100 mg (two capsules). That's the most common community dose. Some users go to 150 mg but side effect reports pick up past that point. The estimated half-life sits around 4 to 6 hours. If you notice an energy dip by early afternoon, splitting your dose (50 mg morning, 50 mg around noon) is a common workaround. No data supports or refutes this; it's community logic based on the PK estimate. Source quality matters more than most people realize. Avoid Amazon and Walmart marketplace listings. No COA accountability exists on those platforms. Buy from specialty research vendors who provide current HPLC certificates of analysis with purity at or above 98%. Underdosing in capsule fill weight is the primary reported quality failure. Store at room temperature. Cool, dry, away from sunlight. Shelf life runs 12 to 24 months.
Dosing based on Community dosing consensus from peptide research communities — 11 published references.View all sources →
Cross-check your 5-Amino-1MQ reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
5-Amino-1MQ blocks the fat-cell enzyme NNMT, boosting NAD+ and cellular energy burn. Mouse studies show dose-dependent fat loss and metabolic improvement; a 2024 study added grip strength gains in aged animals. No human trials exist. Oral capsules are the community standard, though rodent data questions that route. Research compound only.